Jobin K, Hannouf MB, Bahmanyar S, Naseer A, et al. Effectiveness and Toxicity Burden of Pembrolizumab in Combination With
Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A
Real-World Analysis From Alberta, Canada. Am J Clin Oncol 2026 Nov 12. doi: 10.1097/COC.0000000000001399.
PMID: 43018125
|